Iagg workshop: Health promotion program on prevention of late onset dementia

Journal of Nutrition, Health and Aging

Volumn 15, Issue 7, 2011, Pages 562-575

  Andrieu, S ^a   Aboderin, I ^b   Baeyens, J P ^c   Beard, J ^d   Benetos, A ^e   Berrut, G ^f   Brainin, M ^g   Cha, H B ^h   Chen, L K ⁱ   Du, P ^j   Forette, B ^k   Forette, F ^l   Franco, A ^m   Fratiglioni, L ⁿ   Gillette Guyonnet, S ^o   Gold, G ^p   Gomez, F ^q   Guimaraes, R ^r   Gustafson, D ^s   Khachaturian, A ^t   Luchsinger, J ^u   Mangialasche, F ^v   Mathiex Fortunet, H ^w   Michel, J P ^p   Richard, E ^x   Schneider, L S ^y   Solomon, A ^z   Vellas, B ^a   more..

^a TOULOUSE UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c Damiaan General Hospital   (Belgium)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e UNIVERSITY HOSPITAL OF NANCY   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g DANUBE UNIVERSITY KREMS   (Austria)

^h Hallym University   (South Korea)

ⁱ TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^j RENMIN UNIVERSITY OF CHINA   (China)

^k ILC International Longevity Center France   (France)

^l UNIVERSITÉ PARIS DESCARTES   (France)

^m UNIVERSITY HOSPITAL OF NICE   (France)

ⁿ KAROLINSKA INSTITUTE   (Sweden)

^o CHU PURPAN   (France)

^p GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^q UNIVERSIDAD DE CALDAS   (Colombia)

^r UNIVERSITY OF BRASILIA   (Brazil)

^s SUNY DOWNSTATE MEDICAL CENTER   (United States)

^t Campaign to Prevent Alzheimer's Disease   (United States)

^u NewYork Presbyterian Hospital   (United States)

^v UNIVERSITY OF PERUGIA   (Italy)

^w IPSEN's Medical   (France)

^x UNIVERSITY OF AMSTERDAM   (Netherlands)

^y UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^z UNIVERSITY OF EASTERN FINLAND   (Finland)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; OMEGA 3 FATTY ACID;

AGING; COMMUNITY CARE; CONFERENCE PAPER; COST OF ILLNESS; DEMENTIA; EXERCISE; FAMILY COUNSELING; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; HEALTH PROMOTION; HUMAN; META ANALYSIS (TOPIC); PRIORITY JOURNAL; PROPHYLAXIS; QUALITY OF LIFE; RISK FACTOR; SOCIAL NETWORK; SOCIAL STATUS; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

EID: 80054954191     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-011-0142-1     Document Type: Conference Paper

References (6)

1. Schindler RJ. Study design considerations: conducting global clinical trials in early Alzheimer's disease. J Nutr Health Aging. 2010 Apr;14(4):312-4.
2. Cedarbaum JM, Crans G, Grundman M. Seeing with new eyes: finding a path to early intervention trials in Alzheimer's disease. J Nutr Health Aging. 2010 Apr;14(4):306-9.
3. Potter WZ. Dose ranging for trials through biomarkers of drug effects. J Nutr Health Aging. 2010 Apr;14(4):310-1.
4. Gispen-de Wied CC, Kritsidima M, Elferink AJ. The validity of biomarkers as surrogate endpoints in Alzheimer's disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES). J Nutr Health Aging. 2009 Apr;13(4):376-87.
5. Douillet P, Orgogozo JM. What we have learned from the Xaliproden Sanofi-aventis trials. J Nutr Health Aging. 2009 Apr;13(4):365-6.
6. Hendrix SB, Wilcock GK. What we have learned from the Myriad trials. J Nutr Health Aging. 2009 Apr;13(4):362-4. PubMed PMID: 19300881.